Lupus Clinical Trials in New York

Showing 141-160 of 279 trials

Sleep Disordered Breathing and Alzheimer's Disease Biomarkers in Normal Aging and Mild Cognitive Impairment

NCT03912571

The purpose of this study is to determine the sleep patterns of subjects with or without sleep disturbances (insomnia, sleep apnea) and compare these findings with their previous FDG/PIB PET, structural MRI and brain blood flow scams performed during their participation in the Following studies 'Alzheimer's Disease Core Center (ADCC) Clinical Evaluation' (IRB: 2942), MRI Progression Markers of Cognitive Decline in the Elderly' (IRB:09-0586), or 'Imaging Neuro inflammation in Alzheimer's Disease with \[11C\] Arachidonic Acid (AA) and PET'(IRB: 10-00442).

Sleep Disorder

NYU Langone Health28 participantsStarted Nov 2011

New York, New York, United States

COMPLETEDNA< 1 mile

Non-Inferiority Study of the FRESCA Airbox Positive Airway Pressure System

NCT03999944

Prospective, open-label, randomized crossover assignment, multi-center non-inferiority study conducted in the United States

Sleep Apnea

FRESCA Medical52 participantsStarted Oct 2019

St. Petersburg, Florida, United States • Atlanta, Georgia, United States • Gainesville, Georgia, United States +3 more locations

COMPLETEDPhase 2< 1 mile

Pharmacodynamic Profile of SPD489 in Healthy Adult Males Undergoing a Nocturnal Period of Acute Sleep Loss

NCT01096680

This is a double-blind, single center, parallel group, placebo and active comparator, controlled study to characterize the wake promoting effects of single doses of SPD489 in healthy adult male undergoing acute sleep deprivation.

Sleep Deprivation

Shire135 participantsStarted Apr 2010

New York, New York, United States

Sleep Disordered Breathing and Alzheimer's Disease Biomarkers in Normal Aging and Mild Cognitive Impairment

Non-Inferiority Study of the FRESCA Airbox Positive Airway Pressure System

Pharmacodynamic Profile of SPD489 in Healthy Adult Males Undergoing a Nocturnal Period of Acute Sleep Loss

Lupus Trials in Other Cities

World Trade Center Kidney-Link

A Phase II Study of M2951 in SLE

The Efficacy of the Nanit-Insights App in Improving Infant Sleep

Safety Study of Clinical and Immune Effects of Phosphodiesterase 4 (PDE-4) Inhibitor in Cutaneous Lupus Patients

Automated Graduated CPAP (AGPAP) for Improved Adherence in Newly Diagnosed Obstructive Sleep Apnea (OSA) Patients

Evaluation of a Neurostimulation Device for Insomnia: A Randomized Trial

Triptorelin for Ovary Protection in Childhood Onset Lupus

Rituximab and Belimumab for Lupus Nephritis

Acthar Gel for Active Systemic Lupus Erythematosus (SLE)

Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)

Extending Sleep to Reverse Metabolic Syndrome in Middle-aged Adults: Acceptability and Feasibility of a Sleep Intervention

A Pilot Study of Biomarkers in Obstructive Sleep Apnea

Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE)

Using the Cholinergic Anti-Inflammatory Pathway to Treat Systemic Lupus Musculoskeletal Pain

Post Approval Study of the remedē System

Patients With Heart Failure With Preserved Ejection Fraction Adherence to ASV Therapy (PEP ASV)

Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)

Other Conditions in New York